Special Issue: New findings of cellular, molecular, and medical biology using nanotechnology

Submission Deadline: 10 February 2022

Guest Editors:

Dr. Mehran Alavi (Scientists and researcher in nanobiotechnology)

Dr. Danial Kahrizi (Full Professor of Molecular Genetics)

Submission: Please submit the manuscripts to d.kahrizi@cellmolbiol.org

Summary:

Nanotechnology has had an undeniable impact on various aspects of cellular, molecular, and medical biology such as designing cell-based biosensors, high-quality microarrays, efficient anticancer drugs, antimicrobial agents, tissue engineering, and restorative medicine. This technology is based on the synthesis of nanomaterials in the nanometer scale (1-100 nm), which is a key to present progress in all areas of cellular, molecular and medical biology. From a molecular point of view, modern medicine is still in its infancy and nanotechnology can improve it using nanomaterials with related unique properties. With the help of medical nanotechnology, pharmaceutical products can be programmed similar to smart machines and equipped with sensors that can provide products with the ability to detect and treat unhealthy cells. New drugs in nanoscale can reach their suitable distribution, and sustained release of drugs in a target tissue, which is called targeted drug delivery system. Disease prevention and therapy are the remarkable capabilities of cellular and medical nanotechnology. For instance, some metal and metal oxide nanoparticles have shown excellent antimicrobial and anticancer activities in vitro and in vivo. In addition, this technology uses engineered nanodevices and nanostructures to build, control, and repair the biological system at the molecular scale.

Keywords: cellular and molecular biology, medical nanotechnology, nanomaterials, anticancer activity, antimicrobial activity